333 related articles for article (PubMed ID: 23464690)
21. [Risk assessment for familial occurrence of breast cancer].
Chang-Claude J; Becher H; Hamann U; Schroeder-Kurth T
Zentralbl Gynakol; 1995; 117(8):423-34. PubMed ID: 7571905
[TBL] [Abstract][Full Text] [Related]
22. Breast Cancer: Genetics and Risk Assessment.
Tejada-Bergés T
Clin Obstet Gynecol; 2016 Dec; 59(4):673-687. PubMed ID: 27749364
[TBL] [Abstract][Full Text] [Related]
23. Risk assessment and presymptomatic molecular diagnosis in hereditary breast cancer.
Merajver SD; Petty EM
Clin Lab Med; 1996 Mar; 16(1):139-67. PubMed ID: 8867588
[TBL] [Abstract][Full Text] [Related]
24. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
25. [BRCA1 and BRCA2 have reached the clinical medicine. The 10-year old finding of the genetic mutation makes it now possible to prevent breast cancer].
Loman N
Lakartidningen; 2004 Jun; 101(25):2172-7. PubMed ID: 15281304
[TBL] [Abstract][Full Text] [Related]
26. [Tumor risk consultation for predisposed women from high risk cancer families].
Beckmann MW; Niederacher D; Bodden-Heidrich R; Goecke TO; Kuschel B; Achnoula M; Aba F; Schnürch HG; Bender HG
Praxis (Bern 1994); 1998 Apr; 87(15):511-5. PubMed ID: 9608246
[TBL] [Abstract][Full Text] [Related]
27. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics and management strategies in hereditary cancer syndromes.
Hanna NN; Mentzer RM
J Ky Med Assoc; 2003 Mar; 101(3):100-7. PubMed ID: 12674901
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer genetic counseling after diagnosis but before treatment: a pilot study on treatment consequences and psychological impact.
Wevers MR; Hahn DE; Verhoef S; Bolhaar MD; Ausems MG; Aaronson NK; Bleiker EM
Patient Educ Couns; 2012 Oct; 89(1):89-95. PubMed ID: 22543000
[TBL] [Abstract][Full Text] [Related]
30. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.
Di Prospero LS; Seminsky M; Honeyford J; Doan B; Franssen E; Meschino W; Chart P; Warner E
CMAJ; 2001 Apr; 164(7):1005-9. PubMed ID: 11314429
[TBL] [Abstract][Full Text] [Related]
31. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
32. Prophylactic mastectomy and genetic testing: an update.
Houshmand SL; Campbell CT; Briggs SE; McFadden AW; Al-Tweigeri T
Oncol Nurs Forum; 2000; 27(10):1537-47; quiz 1548-9. PubMed ID: 11103373
[TBL] [Abstract][Full Text] [Related]
33. De-mystifying genes: identifying and managing hereditary cancer.
Davies MJ
ONS Connect; 2007; 22(8 Suppl):43-4. PubMed ID: 17824560
[No Abstract] [Full Text] [Related]
34. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
Silva E; Lynch H
Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
[No Abstract] [Full Text] [Related]
35. Hereditary breast cancer: high risk genes, genetic testing and clinical implications.
Hamann U
Clin Lab; 2000; 46(9-10):447-61. PubMed ID: 11034530
[TBL] [Abstract][Full Text] [Related]
36. Hereditary gynecologic cancers: risk assessment, counseling, testing and management.
Ballinger LL
Obstet Gynecol Clin North Am; 2012 Jun; 39(2):165-81. PubMed ID: 22640709
[TBL] [Abstract][Full Text] [Related]
37. Clinical cancer genetics. Part 2: Breast.
Pollock J; Welsh JS
Am J Clin Oncol; 2014 Feb; 37(1):86-9. PubMed ID: 22307211
[TBL] [Abstract][Full Text] [Related]
38. Guidelines for follow-up of women at high risk for inherited breast cancer: consensus statement from the Biomed 2 Demonstration Programme on Inherited Breast Cancer.
Møller P; Evans G; Haites N; Vasen H; Reis MM; Anderson E; Apold J; Hodgson S; Eccles D; Olsson H; Stoppa-Lyonnet D; Chang-Claude J; Morrison PJ; Bevilacqua G; Heimdal K; Maehle L; Lalloo F; Gregory H; Preece P; Borg A; Nevin NC; Caligo M; Steel CM
Dis Markers; 1999 Oct; 15(1-3):207-11. PubMed ID: 10595280
[TBL] [Abstract][Full Text] [Related]
39. Male breast cancer.
Zurrida S; Nolè F; Bonanni B; Mastropasqua MG; Arnone P; Gentilini O; Latronico A
Future Oncol; 2010 Jun; 6(6):985-91. PubMed ID: 20528235
[TBL] [Abstract][Full Text] [Related]
40. Counseling high-risk women about breast cancer.
LeGrazie B
Oncology (Williston Park); 2011 Feb; 25(2 Suppl Nurse Ed):30-5. PubMed ID: 25373281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]